Literature DB >> 3653526

Blood-brain barrier choline transport is reduced in diabetic rats.

A D Mooradian1.   

Abstract

The kinetics of blood-brain barrier (BBB) choline transport in streptozocin-induced diabetic rats were compared with those of age-matched vehicle-injected control rats. The brain uptake index (BUI) of choline in diabetic rats (13.9 +/- 1.1%) was significantly lower than that in control rats (22.6 +/- 0.7%) (P less than .05). This alteration in brain choline uptake appeared to occur in long-standing (9 wk) diabetes. Thus, acute hyperglycemia and diabetes mellitus for shorter periods (3 wk) did not significantly alter the BUI of choline. Insulin (8 U/kg) treatment for 5 days did not alter BUI in diabetic rats (12.9 +/- 0.9%). The maximal velocity of BBB choline transport (Vmax) in diabetic rats (0.14 +/- 0.07 nmol . min-1 . g-1) was significantly lower than the Vmax in control rats (2.2 +/- 0.8 nmol . min-1 . g-1) (P less than .05). The Km of choline transport in diabetic rats (120 +/- 70 microM) was modestly but not significantly lower than that in control animals (400 +/- 160 microM). Similarly, the constant of the nonsaturable component of the transport (Kd) in diabetic animals (0.5 +/- 0.07 microliter . min-1 . g-1) was not significantly different from that in control rats (0.9 +/- 0.3 microliter . min-1 . g-1). The data indicate that diabetes mellitus in rats is associated with a decreased BBB choline transport.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653526     DOI: 10.2337/diab.36.10.1094

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Lipid order and composition of synaptic membranes in experimental diabetes mellitus.

Authors:  A D Mooradian; F Dickerson; T L Smith
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

2.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview.

Authors:  Shikha Prasad; Ravi K Sajja; Pooja Naik; Luca Cucullo
Journal:  J Pharmacovigil       Date:  2014-06

3.  Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.

Authors:  B T Hawkins; T F Lundeen; K M Norwood; H L Brooks; R D Egleton
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

4.  Choline-deprivation alters crucial brain enzyme activities in a rat model of diabetic encephalopathy.

Authors:  Charis Liapi; Argyro Kyriakaki; Apostolos Zarros; Panagiota Galanopoulou; Hussam Al-Humadi; Ismene Dontas; Konstantinos Voumvourakis; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2010-09-14       Impact factor: 3.584

5.  Effects of streptozotocin-induced diabetes on acetylcholine metabolism in rat brain.

Authors:  B Welsh; L Wecker
Journal:  Neurochem Res       Date:  1991-04       Impact factor: 3.996

6.  Alloxan-diabetes alters kinetic properties of the membrane-bound form, but not of the soluble form, of acetylcholinesterase in rat brain.

Authors:  M A Khandkar; E Mukherjee; D V Parmar; S S Katyare
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

Review 7.  The blood-brain barrier as an endocrine tissue.

Authors:  William A Banks
Journal:  Nat Rev Endocrinol       Date:  2019-08       Impact factor: 43.330

8.  Healthy aging and the blood-brain barrier.

Authors:  William A Banks; May J Reed; Aric F Logsdon; Elizabeth M Rhea; Michelle A Erickson
Journal:  Nat Aging       Date:  2021-03-15

Review 9.  The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis.

Authors:  So Yeong Cheon; Juhyun Song
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

10.  Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes.

Authors:  Gregory N Ruegsegger; Shankarappa Manjunatha; Priska Summer; Srinivas Gopala; Piotr Zabeilski; Surendra Dasari; Patrick M Vanderboom; Ian R Lanza; Katherine A Klaus; K Sreekumaran Nair
Journal:  FASEB J       Date:  2019-01-24       Impact factor: 5.834

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.